Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1). (Q38868356)
Jump to navigation
Jump to search
scientific article published on 11 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1). |
scientific article published on 11 May 2016 |
Statements
1 reference
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1). (English)
1 reference
Laure Gossec
1 reference
Vibeke Strand
1 reference
Filip van den Bosch
1 reference
Philip Mease
1 reference
Ori Elkayam
1 reference
James Zuazo
1 reference
Luminita Pricop
1 reference
Shephard Mpofu
1 reference
FUTURE 1 study group
1 reference
11 May 2016
1 reference
1 reference
76
1 reference
1
1 reference
203-207
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference